177 related articles for article (PubMed ID: 38390201)
1. Clinical characteristics and degree of cardiovascular risk factor control in patients with newly-diagnosed type 2 diabetes in Catalonia.
Ramírez-Morros A; Franch-Nadal J; Real J; Miró-Catalina Q; Bundó M; Vlacho B; Mauricio D
Front Endocrinol (Lausanne); 2024; 15():1339879. PubMed ID: 38390201
[TBL] [Abstract][Full Text] [Related]
2. Sex Differences in Cardiovascular Prevention in Type 2: Diabetes in a Real-World Practice Database.
Ramírez-Morros A; Franch-Nadal J; Real J; Gratacòs M; Mauricio D
J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456292
[TBL] [Abstract][Full Text] [Related]
3. Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets' attainment in subjects with and without type 2 diabetes.
Morieri ML; Perrone V; Veronesi C; Degli Esposti L; Andretta M; Plebani M; Fadini GP; Vigili de Kreutzenberg S; Avogaro A
Cardiovasc Diabetol; 2021 Jul; 20(1):144. PubMed ID: 34271920
[TBL] [Abstract][Full Text] [Related]
4. Triglycerides and risk of cardiovascular events in statin-treated patients with newly diagnosed type 2 diabetes: a Danish cohort study.
Kristensen FPB; Christensen DH; Mortensen MB; Maeng M; Kahlert J; Sørensen HT; Thomsen RW
Cardiovasc Diabetol; 2023 Jul; 22(1):187. PubMed ID: 37495999
[TBL] [Abstract][Full Text] [Related]
5. Status of lipid control in Bangladeshi subjects with type 2 diabetes mellitus on lipid-lowering drugs: a multicenter, facility-based, cross-sectional study.
Selim S; Alam MS; Talukder SK; Kabir ML; Gaffar AJ; Kabir MA; Zarin N; Rahman S; Nabi MMU; Mustari M; Hossain MF; Raunak AIB; Hoque MA; Islam MR; Akter F; Hannan MA; Saifuddin M; Asaduzzaman M; Rahman MM; Ahammed A; Rafi MA; Hasan MJ; Kamrul-Hasan ABM
BMC Endocr Disord; 2023 Dec; 23(1):268. PubMed ID: 38053073
[TBL] [Abstract][Full Text] [Related]
6. Metabolic control and cardiovascular risk factors in type 2 diabetes mellitus patients according to diabetes duration.
Franch-Nadal J; Roura-Olmeda P; Benito-Badorrey B; Rodriguez-Poncelas A; Coll-de-Tuero G; Mata-Cases M;
Fam Pract; 2015 Feb; 32(1):27-34. PubMed ID: 25194144
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.
Jurado J; Ybarra J; Solanas P; Caula J; Gich I; Pou JM; Romeo JH
J Am Acad Nurse Pract; 2009 Mar; 21(3):140-8. PubMed ID: 19302689
[TBL] [Abstract][Full Text] [Related]
8. Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines.
Yun SJ; Jeong IK; Cha JH; Lee J; Cho HC; Choi SH; Chun S; Jeon HJ; Kang HC; Kim SS; Ko SH; Koh G; Kwon SK; Lee JH; Moon MK; Noh J; Park CY; Kim S
Diabetes Metab J; 2021 May; 46(3):464-475. PubMed ID: 35235742
[TBL] [Abstract][Full Text] [Related]
9. LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO.
Nag SS; Daniel GW; Bullano MF; Kamal-Bahl S; Sajjan SG; Hu H; Alexander C
J Manag Care Pharm; 2007 Oct; 13(8):652-63. PubMed ID: 17970603
[TBL] [Abstract][Full Text] [Related]
10. Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes.
Strom Williams JL; Lynch CP; Winchester R; Thomas L; Keith B; Egede LE
Diabetes Technol Ther; 2014 Jul; 16(7):421-7. PubMed ID: 24735058
[TBL] [Abstract][Full Text] [Related]
11. Achievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention: Analysis of a large real practice database in Italy.
Presta V; Figliuzzi I; Miceli F; Coluccia R; Fogacci F; Cicero AFG; Ferrucci A; Borghi C; Volpe M; Tocci G;
Atherosclerosis; 2019 Jun; 285():40-48. PubMed ID: 31003091
[TBL] [Abstract][Full Text] [Related]
12. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial.
Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S
JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563
[TBL] [Abstract][Full Text] [Related]
13. Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study.
Yang YS; Yang BR; Kim MS; Hwang Y; Choi SH
Lipids Health Dis; 2020 Jan; 19(1):5. PubMed ID: 31926562
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
[TBL] [Abstract][Full Text] [Related]
15. Relationship between very low low-density lipoprotein cholesterol concentrations not due to statin therapy and risk of type 2 diabetes: A US-based cross-sectional observational study using electronic health records.
Feng Q; Wei WQ; Chung CP; Levinson RT; Sundermann AC; Mosley JD; Bastarache L; Ferguson JF; Cox NJ; Roden DM; Denny JC; Linton MF; Edwards DRV; Stein CM
PLoS Med; 2018 Aug; 15(8):e1002642. PubMed ID: 30153257
[TBL] [Abstract][Full Text] [Related]
16. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
Querton L; Buysschaert M; Hermans MP
J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
[TBL] [Abstract][Full Text] [Related]
17. Cardiometabolic Risk Factors and Incident Cardiovascular Disease Events in Women vs Men With Type 1 Diabetes.
Braffett BH; Bebu I; El Ghormli L; Cowie CC; Sivitz WI; Pop-Busui R; Larkin ME; Gubitosi-Klug RA; Nathan DM; Lachin JM; Dagogo-Jack S;
JAMA Netw Open; 2022 Sep; 5(9):e2230710. PubMed ID: 36074461
[TBL] [Abstract][Full Text] [Related]
18. The Management of Dyslipidaemia in Patients with Type 2 Diabetes Mellitus Receiving Lipid-Lowering Drugs: A Sub-Analysis of the CEPHEUS Findings.
Shehab A; Al-Rasadi K; Arafah M; Al-Hinai AT; Al Mahmeed W; Bhagavathula AS; Al Tamimi O; Al Herz S; Al Anazi F; Al Nemer K; Metwally O; Alkhadra A; Fakhry M; Elghetany H; Medani AR; Yusufali AH; Al Jassim O; Al Hallaq O; Baslaib FOAS; Alawadhi M; Amin H; Al-Hashmi K; Oulhaj A
Curr Vasc Pharmacol; 2018; 16(4):368-375. PubMed ID: 28677510
[TBL] [Abstract][Full Text] [Related]
19. Joint effect of race/ethnicity or location of residence and sex on low density lipoprotein-cholesterol among veterans with type 2 diabetes: a 10-year retrospective cohort study.
Weeda ER; Bishu KG; Ward R; Axon RN; Taber DJ; Gebregziabher M
BMC Cardiovasc Disord; 2020 Oct; 20(1):449. PubMed ID: 33059602
[TBL] [Abstract][Full Text] [Related]
20. Real-world data on metabolic effects of PCSK9 inhibitors in a tertiary care center in patients with and without diabetes mellitus.
Fischer LT; Hochfellner DA; Knoll L; Pöttler T; Mader JK; Aberer F
Cardiovasc Diabetol; 2021 Apr; 20(1):89. PubMed ID: 33894772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
